The latest in substance use disorders and pain management education for healthcare providers

August 2022

EDUCATION

Upcoming Trainings

MACS for MOMs Webinar: Caring for Pregnant Women with OUD During Hospitalization and Postpartum Care After Discharge

Tuesday, September 6 | 2:00 pm

Fight Stigma in the Pharmacy: Using the Right Words to Support Patients with Opioid Use Disorder

Monday, September 12 | 12:00 pm

Half & Half Buprenorphine Waiver Training

Sunday, October 23 | 12:30 - 4:45 pm

In-person at the Maryland Rural Health Conference

MACS ECHO Clinics

This fall, join our virtual ECHO learning communities for continuous case-based discussions and didactic presentations linking expert specialist teams with healthcare providers and their practices.

Stay tuned for details about our fall cycles!

Opioid Treatment Program ECHO Clinic

Learn more

Maternal Health ECHO Clinic

Learn more

Primary Care ECHO Clinic

Learn more

Conferences

Maryland Psychiatric Society Conference

MACS will be tabling

September 7 - 11 | Royal Sonesta Harbor Court Baltimore

Maryland Academy of Physician Assistants (MdAPA) CME Conference

MACS will be tabling

September 14 - 17 | Ocean City, MD

Tuerk Conference on Mental Health and Addiction Treatment

MACS will be tabling

September 15 | Baltimore Convention Center

MAAPC Pharmacology Update 2022

MACS will be tabling

September 24 | Anne Arundel Community College

The 2022 Maryland Rural Health Conference: Defining Rural Health and Putting the Pieces Together

Members of the MACS team will be presenting and tabling

October 24 - 25 | Rocky Gap Resort in Flintstone, MD

Interested in expanding access to services for substance use and chronic pain management?

We are looking for health program specialists to engage Maryland health care providers with MACS services. To learn more about the position and access the application, click the link below.

Come work with us!

NEWS

The Statewide Targeted Overdose Prevention (STOP) Act

During the 2022 Maryland General Assembly the Legislature passed the Statewide Targeted Overdose Prevention (STOP) Act, which will require all homeless services programs, opioid treatment programs, and intensive outpatient treatment programs to provide overdose reversal agents approved by the Food and Drug Administration, like naloxone, to any individual who received treatment for a nonfatal overdose or has been evaluated by a crisis evaluation team. The Maryland Department of Health, through the Center for Harm Reduction Services, will provide naloxone free of charge to any public or private entity that is interested in providing this life saving medication to members of the community. Any entity interested in providing this service should register to become an Overdose Response Program.

August 31^st is Overdose Awareness Day, let us all work together to stem the tide of overdose deaths in the state of Maryland. Learn more...

Increases in Disparities in US Drug Overdose Deaths by Race and Ethnicity

Opportunities for Clinicians and Health Systems

"This Viewpoint summarizes data on the increasing disparities in US drug overdose deaths by race and ethnicity and calls for a multisectoral response that includes structural and policy changes and approaches that focus on racial and ethnic disparities and long-standing inequities that contribute to increased risk for overdose."

Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice

While national guidelines emphasize providing patient-centered care, this review found that only two measures of patient experience incorporated patient preferences and needs out of 31 endorsed OUD quality measures.

First 2 Months of Operation at First Publicly Recognized Overdose Prevention Centers in U.S.

"This quality improvement study investigates outcomes and services used during the first 2 months of operation at the first 2 publicly recognized US overdose prevention centers."

Estimated number of people who inject drugs in the United States

Findings from this study suggest the population size of people who inject drugs (PWID) has substantially grown in the past decade and that prevention services for PWID should be proportionally increased.

Questions about providing services for patients who inject drugs?

Call 1-855-337-MACS

Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: a case report

"This article presents a patient case where a buprenorphine/naloxone micro-dosing regimen was successfully utilized to aid discontinuation of butorphanol nasal spray, assist with opioid tapering, and manage chronic pain in an older adult patient."

New National Mental Health Hotlines to Share with Patients

National Maternal Mental Health Hotline: 1-833-9-HELP4MOMS

Pregnancy and a new baby can bring a range of emotions. Many people feel overwhelmed, sad, anxious, or exhausted at different times during their pregnancy or after having a baby. The National Maternal Mental Health Hotline provides 24/7, free, confidential support before, during, and after pregnancy. Learn more ...

988 Suicide and Crisis Lifeline Launched on 7/16

988 is now the new national suicide and crisis lifeline, a confidential, free service available 24/7/365, connecting those experiencing a mental health, substance use, or suicidal crisis with trained crisis counselors. Learn more...